FR351M - New antibiotic lankavacidin usable in therapy. - Google Patents

New antibiotic lankavacidin usable in therapy.

Info

Publication number
FR351M
FR351M FR836984A FR836984A FR351M FR 351 M FR351 M FR 351M FR 836984 A FR836984 A FR 836984A FR 836984 A FR836984 A FR 836984A FR 351 M FR351 M FR 351M
Authority
FR
France
Prior art keywords
lankavacidin
usable
therapy
new antibiotic
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836984A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7340059A external-priority patent/CH374147A/en
Priority claimed from FR827673A external-priority patent/FR1295910A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR836984A priority Critical patent/FR351M/en
Application granted granted Critical
Publication of FR351M publication Critical patent/FR351M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
FR836984A 1959-05-20 1960-08-29 New antibiotic lankavacidin usable in therapy. Active FR351M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836984A FR351M (en) 1959-05-20 1960-08-29 New antibiotic lankavacidin usable in therapy.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH7340059A CH374147A (en) 1959-05-20 1959-05-20 Process for the production of a new antibiotic
CH127660 1960-02-05
FR827673A FR1295910A (en) 1960-05-19 1960-05-19 Process for preparing two novel antibiotics called <<lankavamycin>> and <<lankavacidin>>, from a strain of streptomyces
FR836984A FR351M (en) 1959-05-20 1960-08-29 New antibiotic lankavacidin usable in therapy.

Publications (1)

Publication Number Publication Date
FR351M true FR351M (en) 1961-03-27

Family

ID=88513714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836984A Active FR351M (en) 1959-05-20 1960-08-29 New antibiotic lankavacidin usable in therapy.

Country Status (1)

Country Link
FR (1) FR351M (en)

Similar Documents

Publication Publication Date Title
FR369M (en) Halogenotetracyclines.
FR308M (en) New pyridyl-ethyl-guanidine usable in therapy.
BE596003A (en) Amino-hydroxy-nitriles.
FR302M (en) New m-butoxy-phenoxy-ethylamine usable in therapy.
FR350M (en) New antibiotic lankavamycin usable in therapy.
FR1898M (en) New substance usable in therapy.
FR352M (en) New ferrimycin antibiotic usable in therapy.
FR351M (en) New antibiotic lankavacidin usable in therapy.
OA01426A (en) Advanced synchro-machines.
DK103424C (en) Høvender.
DK120015B (en) Fluidistor.
BE595070A (en) Plansichter.
FR353M (en) New quinoline usable in therapy.
FR310M (en) New aza-hexylene-imino-ethyl-guanidine usable in therapy.
FR1233212A (en) Cystoscope usable in pediatrics
DK95557C (en) Glashus.
FR222M (en) New 2,5-bis-ethylene-imino-3,6-bis-acylamino-p-benzoquinone usable in therapy.
FR348M (en) New 3,5,6-substituted glucofuranoside usable in therapy.
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
BE596272A (en) New substance usable in therapy.
FR303M (en) New guanidine usable in therapy.
FR3174M (en) New δ-3β17β-dihydroxy-7α17α-dimethyl-19-nor-androstene usable in therapy.
FR163M (en) New phenoxy-ethylamine usable in therapy.
BE583857A (en) Opacifying agent usable in radiology.
FR269M (en) New antibiotic substances.